Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses

Neurochemistry International

Volumn 57, Issue 6, 2010, Pages 662-667

  Sellner, Johann ^a   Cepok, Sabine ^a   Kalluri, Sudhakar Reddy ^a   Nestler, Axel ^a   Kleiter, Ingo ^b   Kümpfel, Tania ^c   Linker, Ralf ^d   Melms, Arthur ^e   Menge, Til ^f   Tumani, Hayrettin ^g   Paul, Friedemann ^h   Hemmer, Bernhard ^a   Berthele, Achim ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ST JOSEF HOSPITAL   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF ULM   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aquaporin 4; Herpes virus; Infection; Multiple sclerosis; Neuromyelitis optica; Pathogenesis

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION; VIRUS VIRULENCE;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6;

EID: 77957020134     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.003     Document Type: Article

References (43)

1. Bennett J.L., Lam C., Kalluri S.R., Saikali P., Bautista K., Dupree C., Glogowska M., Case D., Antel J.P., Owens G.P., Gilden D., Nessler S., Stadelmann C., Hemmer B. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 2009, 66:617-629.
2. Bizzoco E., Lolli F., Repice A.M., Hakiki B., Falcini M., Barilaro A., Taiuti R., Siracusa G., Amato M.P., Biagioli T., Lori S., Moretti M., Vinattieri A., Nencini P., Massacesi L., Mata S. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J. Neurol. 2009, 256:1891-1898.
3. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., Reindl M., Adzemovic M., Bauer J., Berger T., Fujihara K., Itoyama Y., Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66:630-643.
4. Carter C.J. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem. Int. 2008, 52:920-934.
5. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Bussow K., Sommer N., Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 2005, 115:1352-1360.
6. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 2009, 22:76-98.
7. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., Rouse B.T. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 2001, 167:2902-2910.
8. Graber D.J., Levy M., Kerr D., Wade W.F. Neuromyelitis optica pathogenesis and aquaporin 4. J. Neuroinflamm. 2008, 5:22.
9. Heerlein K., Jarius S., Jacobi C., Rohde S., Storch-Hagenlocher B., Wildemann B. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J. Neurol. Sci. 2009, 276:184-186.
10. Hemmer B., Nessler S., Zhou D., Kieseier B., Hartung H.P. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat. Clin. Pract. Neurol. 2006, 2:201-211.
11. Hutt-Fletcher L.M., Balachandran N., Elkins M.H. B cell activation by cytomegalovirus. J. Exp. Med. 1983, 158:2171-2176.
12. Inoue Y. Immunological aspects of herpetic stromal keratitis. Semin. Ophthalmol. 2008, 23:221-227.
13. Jarius S., Franciotta D., Bergamaschi R., Rauer S., Wandinger K.P., Petereit H.F., Maurer M., Tumani H., Vincent A., Eichhorn P., Wildemann B., Wick M., Voltz R. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 2008, 79:1134-1136.
14. Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G., Du Pasquier R.A. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 2008, 131:1712-1721.
15. Kalluri, S.R., Illes, Z., Srivastava, R., Cree, B., Menge, T., Bennett, J.L., Berthele, A., Hemmer, B., 2010. Quantification and functional characterization of antibodies to native aquaporin-4 in neuromyelitis optica. Arch. Neurol. in press.
16. Krone B., Pohl D., Rostasy K., Kahler E., Brunner E., Oeffner F., Grange J.M., Gartner J., Hanefeld F. Common infectious agents in multiple sclerosis: a case-control study in children. Mult. Scler. 2008, 14:136-139.
17. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
18. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spiegelman D., Ascherio A. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005, 293:2496-2500.
19. Li W., Minohara M., Piao H., Matsushita T., Masaki K., Matsuoka T., Isobe N., Su J.J., Ohyagi Y., Kira J.I. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult. Scler. 2009, 15:1411-1421.
20. Lucchinetti C.F., Mandler R.N., McGavern D., Brück W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
21. Lünemann J.D., Munz C. EBV in MS: guilty by association?. Trends Immunol. 2009, 30:243-248.
22. Lünemann J.D., Tackenberg B., Stein A., Wandinger K.P., Oertel W.H., Wagner H.J., Munz C., Meisel H., Sommer N., Zipp F. Dysregulated Epstein-Barr virus infection in patients with CIDP. J. Neuroimmunol. 2010, 218:107-111.
23. Lunardi C., Bason C., Corrocher R., Puccetti A. Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol. 2005, 26:19-24.
24. Matiello M., Lennon V.A., Jacob A., Pittock S.J., Lucchinetti C.F., Wingerchuk D.M., Weinshenker B.G. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70:2197-2200.
25. Matsushita T., Isobe N., Piao H., Matsuoka T., Ishizu T., Doi H., Masaki K., Yoshiura T., Yamasaki R., Ohyagi Y., Kira J.I. Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J. Neurol. Sci. 2010, 291(1-2):37-43.
26. Matsushita T., Matsuoka T., Isobe N., Kawano Y., Minohara M., Shi N., Nishimura Y., Ochi H., Kira J. Association of the HLA-DPB1$0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009, 73:171-176.
27. Paul F., Jarius S., Aktas O., Bluthner M., Bauer O., Appelhans H., Franciotta D., Bergamaschi R., Littleton E., Palace J., Seelig H.P., Hohlfeld R., Vincent A., Zipp F. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007, 4:e133.
28. Persoons M.C., Stals F.S., van dam Mieras M.C., Bruggeman C.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J. Pathol. 1998, 184:103-109.
29. Pittock S.J., Lennon V.A., de Seze J., Vermersch P., Homburger H.A., Wingerchuk D.M., Lucchinetti C.F., Zephir H., Moder K., Weinshenker B.G. Neuromyelitis optica and non-organ-specific autoimmunity. Arch. Neurol. 2008, 65:78-83.
30. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann. Neurol. 2005, 58:840-846.
31. Pordeus V., Szyper-Kravitz M., Levy R.A., Vaz N.M., Shoenfeld Y. Infections and autoimmunity: a panorama. Clin. Rev. Allergy Immunol. 2008, 34:283-299.
32. Sellner J., Dvorak F., Zhou Y., Haas J., Kehm R., Wildemann B., Meyding-Lamade U. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci. Lett. 2005, 374:197-202.
33. Sellner J., Boggild M., Clanet M., du Pasquier R.A., Hintzen R.Q., Illes Z., Montalban X., Polman C., Soelberg Soerensen P., Hemmer B. EFNS Guidelines for Mangement and Treatment of Neuromyelitis optica. Eur. J. Neurol. 2010, 17:1019-1032.
34. Sellner J., Hemmer B., Mühlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. 2010, 34:371-379.
35. Sellner J., Simon F., Meyding-Lamade U., Leib S.L. Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res. 2006, 1125:155-162.
36. Varani S., Frascaroli G., Landini M.P., Soderberg-Naucler C. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity. Rev. Med. Virol. 2009, 19:131-145.
37. Weinshenker B.G., Wingerchuk D.M., Vukusic S., Linbo L., Pittock S.J., Lucchinetti C.F., Lennon V.A. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 2006, 59:566-569.
38. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
39. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.
40. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
41. Zephir H., Fajardy I., Outteryck O., Blanc F., Roger N., Fleury M., Rudolf G., Marignier R., Vukusic S., Confavreux C., Vermersch P., de Seze J. Is neuromyelitis optica associated with human leukocyte antigen?. Mult. Scler. 2009, 15:571-579.
42. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
43. Zinger H., Sherer Y., Goddard G., Berkun Y., Barzilai O., Agmon-Levin N., Ram M., Blank M., Tincani A., Rozman B., Cervera R., Shoenfeld Y. Common infectious agents prevalence in antiphospholipid syndrome. Lupus 2009, 18:1149-1153.